PATENT CLAIM ANALYSIS

Application Number: 16128423
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["530", "300000"]

Abstract:
The present invention provides lyophilized formulations of active agents, particularly of TAT-NR2B9c, as chloride salts. TAT-NR2B9c has shown promise for treating stroke, aneurysm, subarachnoid hemorrhage and other neurological or neurotraumatic conditions. The chloride salt of TAT-NR2B9c shows improved stability compared with the acetate salt form of prior formulations. Formulations of the chloride salt of TAT-NR2B9c are stable at ambient temperature thus facilitating maintenance of supplies of such a formulation in ambulances for administration at the scene of illness or accident or in transit to a hospital.

Claim (Index 8):
The prelyophilized formulation of  claim 6 , wherein the buffer is histidine and the sugar is trehalose and the pH is 6-7.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.49206
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15313940', '15313541', '15210750', '13619576', '11441994']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7086982425133087
- 35 USC 102 Novelty (BERT): 0.6706892804411955
- Combined Prediction Score: 0.7048973463060975
- Mean Citation Score: 479.92039600000015
- Max Citation Score: 664.9222
- Similarity Product: 661.0968361454605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test